Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers

Édith Borcoman, Ana I. Lalanne, Jean‐Pierre Delord, Philippe A. Cassier, Frédéric Rolland, Sébastien Salas, Jean‐Marc Limacher, Olivier Capitain, Olivier Lantz, Christina Ekwegbara, Emmanuelle Jeannot, Joanna Cyrta, Carine Tran‐Perennou, Zahra Castel-Ajgal, Grégoire Marret, Eliane Piaggio, Maud Brandely, Annette Tavernaro, Hakim Makhloufi, Kaïdre Bendjama, Christophe Le Tourneau